Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cancer Science, 2026
Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J‐ TAIL ‐2

Goto Y., Nishio M., Ohashi K. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma

JACC: Basic to Translational Science, 2026
Exercise Reverses Mental Stress–Induced Vascular Inflammation and Builds Stress Resilience

Meyer-Lindemann U., Borbil K., Schwab M. et al.

Olink Target 96 MouseCVDPathophysiologyMouse Plasma

JCI Insight, 2026
NK cell cytotoxicity is transiently enhanced during acute malaria and modulated by the host microenvironment

Xi P., Sandoz P., Lautenbach M. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Cell Reports Medicine, 2026
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity

Ma Y., Zhang A., Lin J. et al.

Olink Target 96Olink Explore 3072/384NeurologyImmunotherapyPathophysiologyCSF

Journal of Clinical Investigation, 2026
Lipoprotein(a)-Associated Proteomic Signature Predicts Cardiovascular Disease in Young Adults

Goonewardena S., Yao S., Jurga T. et al.

Olink Target 96Olink Explore 3072/384CVDPatient StratificationPlasma

Clinical and Translational Science, 2026
GlycA as an Effect Modifier of Protein–Mortality Associations: A Prospective Cohort Study

Wang X., Qiao Z., Tao C. et al.

Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma

British Journal of Dermatology, 2026
A clinically actionable stratification of bullous pemphigoid using a disease activity score reveals a targetable inflammatory endotype

Cao Z., Kong S., Ye J. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationSerum

Communications Biology, 2026
Maternal-infant immune signatures in infants at risk for SARS-CoV-2-associated neurodevelopmental disorders

Fajardo-Martinez V., Ferreira F., Salem G. et al.

Olink Explore 3072/384NeurologyInfectious DiseasesObstetricsPathophysiologySerum

Canadian Journal of Cardiology, 2026
Clinical and community factors' correlation with NT-proBNP in First Nations: a cross-sectional analysis of the CAHHM-FN cohort

Marchand M., Labiba Z., Schulze K. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

PLOS One, 2026
Serum proteomic changes in atopic dermatitis patients treated with cyclosporine

Olydam J., Litman T., Nijsten T. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

Psychoneuroendocrinology, 2026
Investigating the association of a selected inflammatory protein panel with suicide attempts in the PsyCourse Study: A pilot study

Oraki Kohshour M., Budde M., Solomon P. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

The American Journal of Clinical Nutrition, 2026
Plasma proteomics enhances heart failure risk prediction among individuals with type 2 diabetes: a prospective cohort study

Yu H., Zhang J., Qian F. et al.

Olink Explore 3072/384Metabolic DiseasesCVDPatient StratificationPlasma

Environment International, 2026
Association between urban heat island and type 2 diabetes risk: genetic and proteomic insights

Ren J., Sun X., Zhang Z. et al.

Olink Explore 3072/384Metabolic DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma

Clinical Cancer Research, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial

Li Z., Izadmehr S., Hoffman-Censits J. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Brain, 2026
Machine learning model based on plasma proteomics for the identification of Parkinson’s disease

Adewale B., Chia R., Moaddel R. et al.

Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma

Biology of Sex Differences, 2026
Sex differences in proteomic response to ischemic stroke

McLouth C., Hazelwood H., Frank J. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Translational Psychiatry, 2026
Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling

Arjmand S., Chaudhary M., Piehl F. et al.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

Journal of Experimental & Clinical Cancer Research, 2026
Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer

Kurma K., Bardol T., Mollevi C. et al.

Olink Target 96OncologyPatient StratificationPlasma

Cell Genomics, 2026
Interferon-related inflammaging links epigenetic age acceleration to multimorbidity

Liu Z., Ziogas A., Zhang Y. et al.

Olink Target 96AgingPathophysiologyPlasma

JNCI: Journal of the National Cancer Institute, 2026
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators

Wang S., Viallon V., Biessy C. et al.

Olink Target 96OncologyMetabolic DiseasesGynecologyPathophysiologyPlasma

4239 publications